Nuclear autoantigen p330d/CENP-F: A marker for cell proliferation in human malignancies

Cytometry

Volumn 25, Issue 1, 1996, Pages 90-98

  Landberg, Göran ^a   Erlanson, Martin ^a   Roos, Göran ^a   Tan, Eng M ^b   Casiano, Carlos A ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibodies; Cell cycle; Centromere; Flow cytometry; Nuclear matrix; Proliferation

Indexed keywords

AUTOANTIGEN; TUMOR MARKER;

ARTICLE; CANCER; CELL CYCLE; CELL NUCLEUS MATRIX; CELL PROLIFERATION; CENTROMERE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; AUTOANTIGENS; BREAST NEOPLASMS; CELL DIVISION; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; INTERPHASE; MALE; MICROFILAMENT PROTEINS; NUCLEAR MATRIX; S PHASE; TISSUE FIXATION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0029850215     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960901)25:1<90::AID-CYTO10>3.0.CO;2-P     Document Type: Article

References (33)

1. Beppu T, Ishida Y, Arai H, Wada T, Uesugi N, Sasaki K: Identification of S-phase cells with PC10 antibody to proliferating cell nuclear antigen (PCNA) by flow cytometric analysis. J Histochem Cytochem 42:1177-1182, 1994.
2. Bravo R, Macdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 105:1549-1554, 1987.
3. Camplejohn RS: The measurements of intracellular antigens and DNA by multiparametric flow cytometry. J Microsc 176:1-7, 1994.
4. Carmen CW, Isabel Filipe M: Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 25:843-853, 1993.
5. Casiano CA, Humbel RL, Peebles C, Covini G, Tan EM: Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. J Autoimmun 8:575-586, 1995.
6. Casiano CA, Landberg G, Ochs RL, Tan EM: Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci 106:1045-1056, 1993.
7. Clevenger CV, Epstein AL, Bauer KD: Modulation of the nuclear antigen p105 as a function of cell-cycle progression. J Cell Physiol 130:336-343, 1987.
8. Donhuijsen K: Mitosis in non-Hodgkin's lymphomas: Frequency and prognostic relevance. Path Res Pract 182:352-357, 1987.
9. Duchrow M, Gerdes J, Schluter C: The proliferation-associated Ki-67 protein: Definition in molecular terms. Cell Prolif 27:235-242, 1994.
10. Gérard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM: Classification of non-Hodgkin's lymphomas. Lancet 2:406-408, 1974.
11. Hall PA, Coates PJ: Assessment of cell proliferation in pathology: What next? Histopathology 26:105-112, 1995.
12. Hall PA, Woods AL: Immunochemical markers of cellular proliferation: Achievements, problems and prospects. Cell Tissue Kinet 23: 505-522, 1990.
13. He W, Meyer JS, Scrivner DL, Koehm S, Hughes J: Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: Correlation with 5-bromo-2-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis. Biotechnic Histochem 69:203-212, 1994.
14. Landberg G, Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 51:4570-4574, 1991.
15. Landberg G, Roos G: Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Cytometry 13:230-240, 1992.
16. Lenner P, Roos G, Johansson H, Lindh J, Dige U: Non-Hodgkin's lymphoma: Multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol 26:179-183, 1987.
17. Liao H, Winkfein RJ, Mack G, Rattner JB, Yen TJ: CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 130:507-518, 1995.
18. McCormick D, Chong H, Hobbs C, Datta C, Hall PA: Detection of the Ki-67 antigen in fixed and wax embedded section with the monoclonal antibody MIB1. Histopathology 22:355-360, 1993.
19. Mikulka WR, Bolton WE: Methodologies for the preservation of proliferation associated antigens PCNA, p120, and p105 in tumor cell lines for use in flow cytometry. Cytometry 17:246-257, 1994.
20. Morris ES, Elston CW, Bell JA, Galea M, Blamey RW, Ellis IO: An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast. J Pathol 176:55-62, 1995.
21. Rattner JB, Rao A, Fritzler MJ, Valencia DW, Yen TJ: CENP-F is a ca 400 kDa kinetochore protein that exhibits a cell cycle dependant localization. Cell Motil Cytoskeleton 26:214-226, 1993.
22. Rehn S, Glimelius B, Strang P, Sundström C, Tribukait B: Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol 8:1-12, 1990.
23. Roos G, Brattsand G, Landberg G, Marklund U, Gullberg G: Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7:1538-1546, 1993.
24. Sebo TJ, Roche PC. Witzig TE, Kurtin PJ: Proliferative activity in non-Hodgkin's lymphomas. Hematopathology 99:668-672, 1993.
25. Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer. N Engl J Med 322:1045-1053, 1990.
26. Staufenbiel M, Deppert W: Preparation of nuclear matrices from cultured cells: Subfractionation of nuclei in situ. J Cell Biol 98:1886-1894, 1984.
27. Steck K, El-Naggar AK: Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 17:258-265, 1994.
28. Teague K, El-Naggar A: Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Cytometry 15:21-27, 1994.
29. Vindeløv LL: Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch (Cell Pathol) 24:227-242, 1977.
30. Visakorpi T: Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 168:7-13, 1992.
31. Walker RA, Camplejohn RS: Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 57:281-283, 1988.
32. Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121-129, 1990.
33. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA, Bennett MH: Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58:423-431, 1988.